ESR1 and breast cancer: The ERα/β-mediated miR-10b and miR-145 increased MMP2, 7 and 9 expression following overexpression and inhibition, respectively, in ERβ-suppressed MDA-MB-231 breast cancer cells which resulted in increased ERK1/2 activation and aggressive phenotype [97].